Capturing Real World Evidence (RWE) is vital for gaining a competitive edge in an environment where adaptive licensing and pricing pressures are becoming ever more prevalent.
RWE as part of a (managed access) program is the first opportunity to collect data outside the confines of a clinical trial setting, providing valuable information about medicines in the real world population well ahead of launch.
Our RWE offering allows you to capture anonymised data that can help gain unique insights into how patients are diagnosed and treated in a real world setting. Compliant data capture is accompanied by the support of our RWE experts, on hand to answer key questions that allow for better decision-making across all functions within your organisation. Our technology enables the capture and review of data in real time, to support:
- Commercial and Market Access
- Health Economics and Outcomes Research
- Clinical Development and Safety
Our Consulting Services provide tailored solutions for pharmaceutical and biotech companies.